{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:29:34Z","timestamp":1788449374564,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1124\/mol.119.117721","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T18:29:50Z","timestamp":1580754590000},"page":"250-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action"],"prefix":"10.1016","volume":"97","author":[{"given":"A.","family":"Ashna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.","family":"van Helden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"dos Remedios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Laver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.119.117721_bib1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1528-1157.1986.tb03515.x","article-title":"A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy","volume":"27","author":"Andrewes","year":"1986","journal-title":"Epilepsia"},{"key":"10.1124\/mol.119.117721_bib2","doi-asserted-by":"crossref","first-page":"20144","DOI":"10.1074\/jbc.M010771200","article-title":"Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor)","volume":"276","author":"Balshaw","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117721_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.107.153007","article-title":"Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor","volume":"101","author":"Benkusky","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/mol.119.117721_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1124\/mol.119.117721_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1042\/BJ20060377","article-title":"Cardiac ryanodine receptor phosphorylation: target sites and functional consequences","volume":"396","author":"Bers","year":"2006","journal-title":"Biochem J"},{"key":"10.1124\/mol.119.117721_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/jce.12320","article-title":"Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model","volume":"25","author":"Chou","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1124\/mol.119.117721_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM196502112720602","article-title":"Diphenylhydantoin sodium in cardiac arrhythmias","volume":"272","author":"Conn","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.119.117721_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0002-8703(67)90205-0","article-title":"The hemodynamic effects of diphenylhydantoin","volume":"73","author":"Conn","year":"1967","journal-title":"Am Heart J"},{"key":"10.1124\/mol.119.117721_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(77)90930-1","article-title":"Antagonistic action of diphenylhydantoin and calcium on the level of phosphorylation of particular rat and human brain proteins","volume":"134","author":"DeLorenzo","year":"1977","journal-title":"Brain Res"},{"key":"10.1124\/mol.119.117721_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0006-8993(76)90440-6","article-title":"Effect of diphenylhydantoin on the endogenous phosphorylation of brain protein","volume":"105","author":"Delorenzo","year":"1976","journal-title":"Brain Res"},{"key":"10.1124\/mol.119.117721_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ceca.2007.04.002","article-title":"Analysis of cellular calcium fluxes in cardiac muscle to understand calcium homeostasis in the heart","volume":"42","author":"Dibb","year":"2007","journal-title":"Cell Calcium"},{"key":"10.1124\/mol.119.117721_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1113\/jphysiol.1967.sp008367","article-title":"Co-operative action a calcium ions in transmitter release at the neuromuscular junction","volume":"193","author":"Dodge Jr.","year":"1967","journal-title":"J Physiol"},{"key":"10.1124\/mol.119.117721_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/bmj.4.5678.270","article-title":"Treatment of cardiac arrhythmias with phenytoin","volume":"4","author":"Eddy","year":"1969","journal-title":"BMJ"},{"key":"10.1124\/mol.119.117721_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ Res"},{"key":"10.1124\/mol.119.117721_bib15","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.1983.245.1.C1","article-title":"Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum","volume":"245","author":"Fabiato","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.119.117721_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yjmcc.2007.05.022","article-title":"Ca2+\/calmodulin kinase II increases ryanodine binding and Ca2+-induced sarcoplasmic reticulum Ca2+ release kinetics during beta-adrenergic stimulation","volume":"43","author":"Ferrero","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.119.117721_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2006.08.115","article-title":"Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies","volume":"42","author":"George","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.119.117721_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.RES.0000199296.70534.7c","article-title":"Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction","volume":"98","author":"George","year":"2006","journal-title":"Circ Res"},{"key":"10.1124\/mol.119.117721_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archneur.1974.00490400064007","article-title":"Diphenylhydantoin and calcium movement in lobster nerves","volume":"31","author":"Hasbani","year":"1974","journal-title":"Arch Neurol"},{"key":"10.1124\/mol.119.117721_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yjmcc.2009.10.005","article-title":"Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass","volume":"48","author":"Hilliard","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.119.117721_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCEP.110.959916","article-title":"Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Hwang","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1124\/mol.119.117721_bib22","doi-asserted-by":"crossref","first-page":"d671","DOI":"10.2741\/ikemoto","article-title":"Regulation of calcium release by interdomain interaction within ryanodine receptors","volume":"7","author":"Ikemoto","year":"2002","journal-title":"Front Biosci"},{"key":"10.1124\/mol.119.117721_bib23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.RES.0000192146.85173.4b","article-title":"Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death","volume":"97","author":"Jiang","year":"2005","journal-title":"Circ Res"},{"key":"10.1124\/mol.119.117721_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.CIR.99.1.65","article-title":"Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure","volume":"99","author":"Kaumann","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/mol.119.117721_bib25","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1074\/jbc.M408375200","article-title":"Dantrolene stabilizes domain interactions within the ryanodine receptor","volume":"280","author":"Kobayashi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117721_bib26","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2009.01.065","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor","volume":"53","author":"Kobayashi","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/mol.119.117721_bib27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(25)38428-4","article-title":"Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells","volume":"266","author":"Lang","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.119.117721_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1440-1681.2001.03503.x","article-title":"The power of single channel recording and analysis: its application to ryanodine receptors in lipid bilayers","volume":"28","author":"Laver","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/mol.119.117721_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2012.10.009","article-title":"Termination of calcium-induced calcium release by induction decay: an emergent property of stochastic channel gating and molecular scale architecture","volume":"54","author":"Laver","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.119.117721_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00235394","article-title":"Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle","volume":"147","author":"Laver","year":"1995","journal-title":"J Membr Biol"},{"key":"10.1124\/mol.119.117721_bib31","doi-asserted-by":"crossref","first-page":"H953","DOI":"10.1152\/ajpheart.00936.2011","article-title":"Dantrolene prevents arrhythmogenic Ca2+ release in heart failure","volume":"302","author":"Maxwell","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/mol.119.117721_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/bioinformatics\/btv725","article-title":"Prediction of the permeability of neutral drugs inferred from their solvation properties","volume":"32","author":"Milanetti","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1124\/mol.119.117721_bib33","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/01.CIR.102.15.1814","article-title":"Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein","volume":"102","author":"Molenaar","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/mol.119.117721_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12028-008-9133-4","article-title":"Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit","volume":"10","author":"Muehlschlegel","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1124\/mol.119.117721_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/mol.115.097691","article-title":"Essential role of calmodulin in RyR inhibition by dantrolene","volume":"88","author":"Oo","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.119.117721_bib36","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/js980111k","article-title":"Link between drug absorption solubility and permeability measurements in Caco-2 cells","volume":"87","author":"Pade","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1124\/mol.119.117721_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3797\/scipharm.1109-03","article-title":"Validated HPLC method for concurrent determination of antipyrine, carbamazepine, furosemide and phenytoin and its application in assessment of drug permeability through caco-2 cell monolayers","volume":"80","author":"Patil","year":"2012","journal-title":"Sci Pharm"},{"key":"10.1124\/mol.119.117721_bib38","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117721_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneur.1973.00490280051007","article-title":"Diphenylhydantoin and calcium. Relation to norepinephrine release from brain slices","volume":"29","author":"Pincus","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1124\/mol.119.117721_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9109503","article-title":"Antiarrhythmic effects of carvedilol and flecainide in cardiomyocytes derived from catecholaminergic polymorphic ventricular tachycardia patients","volume":"2018","author":"P\u00f6l\u00f6nen","year":"2018","journal-title":"Stem Cells Int"},{"key":"10.1124\/mol.119.117721_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1994.tb01640.x","article-title":"Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients","volume":"89","author":"Pulliainen","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1124\/mol.119.117721_bib42","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1528-1157.1995.tb01062.x","article-title":"Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up","volume":"36","author":"Pulliainen","year":"1995","journal-title":"Epilepsia"},{"key":"10.1124\/mol.119.117721_bib43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9149(67)90011-2","article-title":"Diphenylhydantoin in cardiac arrhythmias","volume":"20","author":"Rosen","year":"1967","journal-title":"Am J Cardiol"},{"key":"10.1124\/mol.119.117721_bib44","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jps.2600660724","article-title":"Solubility and ionization characteristics of phenytoin","volume":"66","author":"Schwartz","year":"1977","journal-title":"J Pharm Sci"},{"key":"10.1124\/mol.119.117721_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.RES.0000079967.11815.19","article-title":"Ca2+ scraps: local depletions of free [Ca2+] in cardiac sarcoplasmic reticulum during contractions leave substantial Ca2+ reserve","volume":"93","author":"Shannon","year":"2003","journal-title":"Circ Res"},{"key":"10.1124\/mol.119.117721_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.2044-8260.1981.tb00513.x","article-title":"Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy","volume":"20","author":"Thompson","year":"1981","journal-title":"Br J Clin Psychol"},{"key":"10.1124\/mol.119.117721_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3565(25)21001-1","article-title":"Mechanisms of calcium channel block by phenytoin","volume":"246","author":"Twombly","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.119.117721_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yjmcc.2019.03.018","article-title":"Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814","volume":"130","author":"Walweel","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.119.117721_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2017.01.016","article-title":"2+ 2+ in healthy and failing human hearts","volume":"104","author":"Walweel","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.119.117721_bib50","doi-asserted-by":"crossref","first-page":"17785","DOI":"10.1074\/jbc.M700660200","article-title":"Localization of an NH(2)-terminal disease-causing mutation hot spot to the \u201cclamp\u201d region in the three-dimensional structure of the cardiac ryanodine receptor","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117721_bib51","doi-asserted-by":"crossref","first-page":"12202","DOI":"10.1074\/jbc.M110.194316","article-title":"Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117721_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.410200202","article-title":"Phenytoin: mechanisms of its anticonvulsant action","volume":"20","author":"Yaari","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.119.117721_bib53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1006\/bbrc.2002.6569","article-title":"Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor","volume":"291","author":"Yamamoto","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.119.117721_bib54","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/bi015581z","article-title":"Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor","volume":"41","author":"Yamamoto","year":"2002","journal-title":"Biochemistry"},{"key":"10.1124\/mol.119.117721_bib55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pharmthera.2005.04.003","article-title":"Abnormal ryanodine receptor function in heart failure","volume":"107","author":"Yano","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.119.117721_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.RES.59.3.356","article-title":"Diphenylhydantoin blocks cardiac calcium channels and binds to the dihydropyridine receptor","volume":"59","author":"Yatani","year":"1986","journal-title":"Circ Res"},{"key":"10.1124\/mol.119.117721_bib57","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1038\/ncomms8947","article-title":"Crystal structures of ryanodine receptor SPRY1 and tandem-repeat domains reveal a critical FKBP12 binding determinant","volume":"6","author":"Yuchi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/mol.119.117721_bib58","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0006-3495(95)80048-2","article-title":"Description of modal gating of the cardiac calcium release channel in planar lipid membranes","volume":"69","author":"Zahradn\u00edkov\u00e1","year":"1995","journal-title":"Biophys J"},{"key":"10.1124\/mol.119.117721_bib59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pharmthera.2005.04.006","article-title":"Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling","volume":"108","author":"Zheng","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.119.117721_bib60","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1161\/CIRCRESAHA.107.183236","article-title":"Termination of cardiac Ca2+ sparks: role of intra-SR [Ca2+], release flux, and intra-SR Ca2+ diffusion","volume":"103","author":"Zima","year":"2008","journal-title":"Circ Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.119.117721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:32:00Z","timestamp":1739961120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24009805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0026895X24009805"],"URL":"https:\/\/doi.org\/10.1124\/mol.119.117721","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.119.117721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}